Liquidia Corporation
๋กฑ

LQDA Technical Analysis ๐Ÿง™

266
Liquidia Corp, formerly Liquidia Technologies Inc is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Liquidia is developing two product candidates from its own pipeline: LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain.

If you want more trading ideas like this one ,๐ŸŽฏ press a thumb up! ๐Ÿ‘ Have a question? Don't be shy to ask! ๐Ÿค“ Interested to study how to analyze charts, follow me!

๋ฉด์ฑ…์‚ฌํ•ญ

ํ•ด๋‹น ์ •๋ณด์™€ ๊ฒŒ์‹œ๋ฌผ์€ ๊ธˆ์œต, ํˆฌ์ž, ํŠธ๋ ˆ์ด๋”ฉ ๋˜๋Š” ๊ธฐํƒ€ ์œ ํ˜•์˜ ์กฐ์–ธ์ด๋‚˜ ๊ถŒ์žฅ ์‚ฌํ•ญ์œผ๋กœ ๊ฐ„์ฃผ๋˜์ง€ ์•Š์œผ๋ฉฐ, ํŠธ๋ ˆ์ด๋”ฉ๋ทฐ์—์„œ ์ œ๊ณตํ•˜๊ฑฐ๋‚˜ ๋ณด์ฆํ•˜๋Š” ๊ฒƒ์ด ์•„๋‹™๋‹ˆ๋‹ค. ์ž์„ธํ•œ ๋‚ด์šฉ์€ ์ด์šฉ ์•ฝ๊ด€์„ ์ฐธ์กฐํ•˜์„ธ์š”.